CeGaT
In Brief This Week: QuidelOrtho, Revvity, CeGaT, Mindera Health, Fluxergy, NeuroKaire, More
News items for the week of Nov. 18, 2024.
German Precision Medicine Model Project Gets Ready for Kickoff as Commercial Providers Cry Foul
The €700 million project will pilot diagnostic genomic testing for cancer and rare diseases for at least five years, but private labs cannot participate.
In Brief This Week: Roche, Labcorp, Aspira Women's Health, Mainz Biomed, More
News items for the week of April 11, 2024
CeGaT Receives CE Mark for Coronavirus Antibody Test
The test is designed to detect immunoglobulin G antibodies against the S1 domain of the SARS-CoV-2 spike protein in blood samples.
The company's assay relies on a set of 15 methylation and microRNA markers to determine whether a woman has breast cancer.
Jul 16, 2018
Feb 10, 2017